Advantages of an alternative strategy based on consecutive HIV serological tests for detection of HIV antibodies in Central African Republic

Journal of Virological Methods

Volumn 111, Issue 2, 2003, Pages 129-134

  Ménard, Didier ^a   Mavolomadé, Elisa Euridice ^a   Mandeng, Marie Joëlle ^a   Talarmin, Antoine ^a  

^a INSTITUT PASTEUR DE BANGUI   (Central African Republic)

Author keywords

Africa; Algorithm; Central African Republic; Consecutive testing strategy; HIV antibodies testing; HIV 1; HIV 2; Serological test

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; AUTOMATION; CENTRAL AFRICA; CHROMATOGRAPHY; COMPARATIVE STUDY; DETERMINE ABBOTT; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; LABORATORY TEST; MEDICAL SOCIETY; NONHUMAN; OPTICAL DENSITY; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SERODIAGNOSIS; VIDAS HUMAN IMMUNODEFICIENCY VIRUS DUO; VIRUS TYPING; WORLD HEALTH ORGANIZATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 0038444416     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(03)00169-1     Document Type: Article

References (25)

1. Arai H., Petchelai B., Khupulsup, et al. Evaluation of rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus. J. Clin. Microbiol. 37:1999;367-370.
2. Bakari J.P., Mc Kenna S., Myrick A., Mwinga K., Bhat G.J., Allen S. Rapid voluntary testing and conseling for HIV. Ann. NY Acad. Sci. 918:2000;64-76.
3. Behets F., Bishagara K., Disasi A., et al. Diagnosis of HIV infection with instrument-free assays as an alternative to the ELISA and Western blot testing strategy: an evaluation in Central Africa. J. Acq. Immun. Def. Synd. 5:1992;878-882.
4. Carvalho M.B., Hamerschlak N., Vaz R.S., et al. Risk factor analysis and serological diagnosis of HIV-l/HIV-2 infection in a Brazilian blood donor population: validation of the World Health Organisation Strategy for HIV testing. AIDS. 10:1996;1135-1140.
5. Fonseca K., Anand C. Predicting human immunodeficiency virus type-positive sera by using enzyme immunoassay kits in a parallel testing format. J. Clin. Microbiol. 29:1991;2597-2612.
6. Ittiravivongs A., Likanosakul S., Mastro T.D., et al. Evaluation of a confirmatory HIV testing strategy in Thailand not using Western blot. J. Acq. Immun. Def. Synd. 13:1996;296-297.
7. Keenan P.A., Keenan J.M. Rapid HIV testing in urban outreach: a strategy for improving post-test counseling rates. AIDS Educ. Prev. 13:(6):2001;541-550.
8. Laperche, S., Maniez-Montreuil, M., Couroucé, A.M., 2001. Evaluation comparative des tests de dépistage combiné de l'Ag P24 et des anticorps anti-VIH. XIIIe colloque de virologie de Versailles-Le Chesnay.
9. Lien T.X., Tien N.T., Chanpong G.F., et al. Evaluation of rapid diagnostic tests for the detection of human immunodeficiency virus types 1 and 2, hepatitis B surface antigen, and syphilis in Ho Chi Minh City. Vietnam Am. J. Trop. Med. Hyg. 62:2000;301-309.
10. Mc Kenna, S.L., Muyindat, G.K., Roth, D., eta al., 1997. Rapid HIV testing and counselling for voluntary testing centers in Africa. AIDS 11 (suppl): S103-S110.
11. Mitchell S., Mboup S., Minge J., et al. Field evaluation of alternative HIV testing strategy with a rapid immunobinding assay and an agglutination assay. Lancet. 37:1991;1328-1331.
12. Mortimer J. An altemative approach to confirming anti-HIV reactivity a multi country collaborative study. Bull. WHO. 70:1992;751-756.
13. Nkengasong J., van Kerckhoven I., Vercauteren G., et al. Alternative confirmatory strategy for anti-HIV antibody detection. J. Virol. Methods. 36:1992;159-170.
14. Nunn A.I., Biryahwaho B., Downing R.G., et al. Algorithms for detecting antibodies to HIV-I: results from a rural Ugandan cohort. AIDS. 7:1993;1057-1061.
15. Palmer C.J., Dubon J.M., Koenig E., et al. Field evaluation of the Determine rapid human immunodeficiency virus diagnostic test in Honduras and the Dominican Republic. J. Clin. Microbiol. 37:1999;3698-3700.
16. Pison, G., 2000. Population and company no. 370, July August 2000.
17. Spielberg F., Mulanga Kabeya C., Quinn T., et al. Performance and cost effectiveness of a dual rapid assay system for screening and confirmation of human immunodeficiency virus type 1 seropositivity. J. Clin. Microbiol. 28:1990;303-306.
18. Tamashiro H., Maskill W., Emmanuel I., et al. Reducing the cost of HIV antibody testing. Lancet. 342:1993;87-90.
19. Thorstensson R., Gaines H., Biberfeld O. Large-scale evaluation of an alternative strategy for confirmation of HIV antibodies. Clin. Diagn. Virol. 4:1995;15-25.
20. Urassa W., Bredberg-Raden U., Mbena E., et al. Alternative confirmatory strategies in HIV-1 antibody testing. J. Acq. Immunol. Def. Synd. 5:1992;170-176.
21. Urassa W., Matunda S., Bredberg-Raden U., et al. Evaluation of the WHO human immunodeficiency virus (HIV) antibody testing strategy for the diagnosis of HIV infection. Clin. Diagn. Virol. 2:1994;1-6.
22. Van der Groen G., van Kerckhoven I., Vercauteren G., et al. Simplified and less expensive confirmatory HIV testing. Bull. WHO. 69:1991;747-752.
23. WHO, 1992. WHO recommendation for HIV antibody testing. Wkly Epidem Rec., 67, 145-152.
24. WHO, 1997. Revised recommendations for the selection and use of HIV antibody tests. Wkly Epidem Rec., 72, 81-88.
25. Zaaijer H.L., Exel.Oehlers P., Kraaijeveld T., et al. Early detection of antibodies to HIV-1 by third-generation assays. Lancet. 340:1992;770-772.